SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000909567-02-000106
Filing Date
2002-12-16
Accepted
2002-12-16 15:41:06
Documents
7
Period of Report
2002-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F t08518e20vf.htm 20-F 728811
3 INDUSTRIAL LEASE t08518exv4w2.txt EX-4.2 77834
4 CERTIFICATION - JIM A. WRIGHT t08518exv10w1.txt EX-10.1 1254
5 CERTIFICATION - JAMES T. PARSONS t08518exv10w2.txt EX-10.2 1337
6 GRAPHIC t08518t08518z0001.gif GRAPHIC 16611
7 GRAPHIC t08518t08518z0003.gif GRAPHIC 929
8 GRAPHIC t08518t08518z0002.gif GRAPHIC 1089
  Complete submission text file 0000909567-02-000106.txt   830376
Mailing Address 2 MERIDIAN ROAD TORONTO ONTARIO M9W A6 0000
Business Address 1285 MORNINGSIDE AVE SCARBOROUGH ONTARIO M1B 3W2 CANADA M1B 3W2 A6 M3B 1Y8
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 000-19763 | Film No.: 02858661
SIC: 2836 Biological Products, (No Diagnostic Substances)